Sutro Logo high res
  • Who We Are
    • About Sutro
    • Leadership
      • Leadership Team
      • Board of Directors
      • Scientific Advisory Board
      • Clinical Advisory Board
    • Collaborations
  • Proprietary Platform
  • Pipeline
    • Overview
    • Scientific Publications
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Financials
    • Stock Data
    • Governance
    • IR Resources
  • Careers
    • The Way We Work
    • DEIB
    • Sustainability
    • Internships
    • Philanthropy
      • Employee Engagement
  • Contact Us

Sutro Biopharma Receives the Pantheon 2015 DiNA Outstanding Partner Award by the California Life Sciences Association

Events

Sutro Biopharma Receives the Pantheon 2015 DiNA Outstanding Partner Award by the California Life Sciences Association SAN FRANCISCO, Nov. 18, 2015 /PRNewswire/ — Sutro Biopharma today announced that it was awarded the Outstanding Partner Award, at the California...

FierceBiotech names Sutro Biopharma as one of its “Fierce 15” Biotech Companies of 2014

Events

FierceBiotech names Sutro Biopharma as one of its “Fierce 15” Biotech Companies of 2014   San Francisco, CA – September 22, 2014 – Sutro Biopharma today announced that it has been named by FierceBiotech as one of 2014’s Fierce 15 biotechnology companies,...

Sutro Biopharma’s Xpress CF+™ Technology Nominated for Best Scientific Innovation by World ADC

Events

Sutro Biopharma’s Xpress CF+™ Technology Nominated for Best Scientific Innovation by World ADC On July 1, 2014, World ADC announced the nominees for the World ADC Awards, 2014. Sutro Biopharma’s cell free expression system, Xpress CF+™, has made the...

EnWave Signs Commercial License with Sutro Biopharma for powderREV® Technology

Events, News

EnWave Signs Commercial License with Sutro Biopharma for powderREV® Technology Press release published by EnWave Corporation regarding the recent agreement with Sutro Biopharma, Inc. Read...

Antibody-Drug Conjugates and Cancer Treatment: Making “Smart Bombs” Smarter

Events

Antibody-Drug Conjugates and Cancer Treatment: Making “Smart Bombs” Smarter Scientific American Guest Blog Antibody-Drug Conjugates and Cancer Treatment: Making “Smart Bombs” Smarter By: Trevor J. Hallam Read...

Sutro Biopharma’s Trevor Hallam Offers a Glimpse into the Future of Drug Design

Events

Sutro Biopharma’s Trevor Hallam Offers a Glimpse into the Future of Drug Design 12/5/2011 – BioPharm International Podcast (3of3): Sutro Biopharma’s Trevor Hallam offers a glimpse into the future of drug design By: Trevor J....
« Older Entries
Next Entries »

Sutro Biopharma

111 Oyster Point Blvd
South San Francisco, CA 94080

Phone: 650-881-6500

Dedicated to patients
and changing the future of oncology

  • Follow
  • Follow
  • Follow
  • Follow

Follow us on social media

© 2026 Sutro Biopharma, Inc.
South San Francisco, California, U.S.A.

SITE MAP | PRIVACY POLICY  | EMAIL ALERTS | CONTACT US | VISITOR GUIDE

 

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Sutro Biopharma, Inc.
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.